Literature DB >> 1929274

In vitro and in vivo studies of ME1228, a new parenteral cephalosporin with potent activity against Pseudomonas aeruginosa.

S Miyazaki1, Y Miyazaki, A Tsuji, M Nishida, S Goto.   

Abstract

The therapeutic effect of ME1228, a new parenteral cephalosporin, was compared with that of broad-spectrum cephems in normal and neutropenic mice infected with various species of bacteria. The results showed that ME1228 was more active than were the other cephems against infections with various pathogens.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1929274      PMCID： PMC284323          DOI： 10.1128/AAC.35.6.1245

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  2 in total

1.  A new aminothiazolylcephalosporin having 1-carboxyethoxyimino group, ME1228.

Authors:  S Shibahara; T Okonogi; T Yoshida; Y Murai; T Kudo; S Inouye; S Kondo
Journal:  J Antibiot (Tokyo)       Date:  1990-01       Impact factor: 2.649

2.  In vitro activity of ME1228, a new parenteral cephalosporin.

Authors:  H C Neu; G Saha; N X Chin
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.